Aptamer Group (LSE:APTA) Debt-to-Equity : 0.53 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Aptamer Group Debt-to-Equity?

Aptamer Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.41 Mil. Aptamer Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £0.64 Mil. Aptamer Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was £1.99 Mil. Aptamer Group's debt to equity for the quarter that ended in Dec. 2023 was 0.53.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Aptamer Group's Debt-to-Equity or its related term are showing as below:

LSE:APTA' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.16 Max: 3.55
Current: 0.53

During the past 4 years, the highest Debt-to-Equity Ratio of Aptamer Group was 3.55. The lowest was 0.02. And the median was 0.16.

LSE:APTA's Debt-to-Equity is ranked worse than
75.75% of 1068 companies
in the Biotechnology industry
Industry Median: 0.14 vs LSE:APTA: 0.53

Aptamer Group Debt-to-Equity Historical Data

The historical data trend for Aptamer Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group Debt-to-Equity Chart

Aptamer Group Annual Data

Trend

Mar19

Mar20

Jun22

Jun23

Debt-to-Equity

0.08

0.65

0.16

3.55

Aptamer Group Semi-Annual Data
	Mar19	Mar20	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			0.02	0.16	0.07	3.55	0.53

Competitive Comparison of Aptamer Group's Debt-to-Equity

For the Biotechnology subindustry, Aptamer Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aptamer Group's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptamer Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Aptamer Group's Debt-to-Equity falls into.

Aptamer Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Aptamer Group's Debt to Equity Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.314	+	0.764)	/	0.304
	=	3.55

Aptamer Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.412	+	0.644)	/	1.99
	=	0.53

Aptamer Group (LSE:APTA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Aptamer Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Aptamer Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptamer Group (LSE:APTA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (LSE:APTA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

P0J:Germany

Address

Innovation Way, Windmill House, York, GBR, YO10 5BR

Website

https://www.aptamergroup.com

Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics.

Aptamer Group (LSE:APTA) Headlines

No Headlines